Last update 08 May 2025

UCMSC therapy(Ivy Institute of Stem Cells)

Overview

Basic Info

Drug Type
Mesenchymal stem cell therapy
Synonyms-
Target-
Action-
Mechanism
Cell replacements
Therapeutic Areas
Immune System DiseasesNervous System DiseasesCardiovascular Diseases+ [3]
Active Indication-
Inactive Indication
Angina PectorisColitis, UlcerativeHeart Failure+ [3]
Originator Organization
Ivy Institute of Stem Cells Co. Ltd
Active Organization-
Inactive Organization
Ivy Institute of Stem Cells Co. Ltd
License Organization-
Drug Highest PhasePendingPhase 1/2
First Approval Date-
Regulation-
Login to view timeline

Related

4
Clinical Trials associated with UCMSC therapy(Ivy Institute of Stem Cells)
NCT02444455
/ Unknown statusPhase 1/2IIT
Safety and Efficacy of Human Umbilical-Cord-Derived Mesenchymal Stem Cell Transplantation in Acute Lung Injury
NCT02442037
/ Unknown statusPhase 1/2IIT
Safety and Efficacy of Human Umbilical-Cord-derived Mesenchymal Stem Cell Transplantation in Active Ulcerative Colitis.
NCT02444858
/ Unknown statusPhase 1/2IIT
Safety and Efficacy of Human Umbilical-Cord-derived Mesenchymal Stem Cell Transplantation in Paraquat Poisoning Induced Lung Injury
100 Clinical Results associated with UCMSC therapy(Ivy Institute of Stem Cells)
Login to view more data
100 Translational Medicine associated with UCMSC therapy(Ivy Institute of Stem Cells)
Login to view more data
100 Patents (Medical) associated with UCMSC therapy(Ivy Institute of Stem Cells)
Login to view more data
100 Deals associated with UCMSC therapy(Ivy Institute of Stem Cells)
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Angina PectorisPhase 2
China
Ivy Institute of Stem Cells Co. Ltd
01 May 2015
Colitis, UlcerativePhase 2
China
Ivy Institute of Stem Cells Co. Ltd
01 May 2015
Heart FailurePhase 2
China
Ivy Institute of Stem Cells Co. Ltd
01 May 2015
Ischemic cardiomyopathyPhase 2
China
Ivy Institute of Stem Cells Co. Ltd
01 May 2015
Paraquat LungPhase 2
China
Ivy Institute of Stem Cells Co. Ltd
01 May 2015
Respiratory Distress Syndrome, AdultPhase 2
China
Ivy Institute of Stem Cells Co. Ltd
01 May 2015
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free